Salix Coronary Plaque vs CAC Software
AI Verdict
Choose Salix Coronary Plaque if…
Choose Salix Coronary Plaque if you require a comprehensive, near real-time assessment of coronary artery disease directly from CCTA scans. This tool is ideal for identifying and quantifying not only stenosis and calcifications but also high-risk plaque features, enabling rapid, point-of-care diagnostic and treatment decisions.
View Salix Coronary Plaque →Choose CAC Software if…
Choose Imbio's CAC Software if your primary need is automated and precise quantification of coronary artery calcification from non-contrast chest CT scans. This solution is best suited for efficient risk assessment of coronary artery disease using standardized scores like the Agatston score, and for seamless integration into existing DICOM viewing workflows.
View CAC Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Salix Coronary Plaque | CAC Software |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud | Cloud, On-premise, Partner platforms |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CAC SoftwareTool B emphasizes a fully automated, 'no user input or intervention' approach for its core analysis, seamlessly integrating into existing DICOM workflows without requiring new interfaces. While Tool A offers an intuitive web-based platform with minimal training, Tool B's hands-off processing for initial analysis provides a slight edge in pure 'usability' by reducing clinician interaction.
Clinical Value
Salix Coronary PlaqueTool A provides a more comprehensive clinical assessment by not only quantifying calcifications but also detecting and characterizing coronary plaque (atherosclerosis), identifying high-risk plaque features, and assessing stenosis from CCTA scans. This offers deeper, more actionable insights into coronary artery disease beyond basic calcium scoring.
Pricing & Value
Salix Coronary PlaqueTool A clearly articulates its financial value proposition by mentioning a US CPT reimbursement rate of US$950 per assessment and the potential to generate revenue for healthcare providers. It also highlights minimal upfront investment. Tool B only states 'Contact for pricing' without further details, making its economic value less transparent.
Enterprise Readiness
CAC SoftwareTool B offers greater deployment flexibility, supporting Cloud, On-premise, and Partner platforms, which caters to diverse institutional IT infrastructures and preferences. It also explicitly states HIPAA compliance and BAA availability in its specifications. While Tool A lists extensive compliance certifications, its deployment is primarily cloud-based according to its primary descriptions.
Innovation
Salix Coronary PlaqueTool A demonstrates greater innovation by moving beyond standard calcium scoring to offer comprehensive plaque characterization, including the identification of high-risk plaque features and stenosis assessment from CCTA. This provides a more advanced and nuanced understanding of coronary artery disease, representing a significant step forward in diagnostic capabilities.
Support & Docs
CAC SoftwareTool B provides explicit details about its support channels, including phone and email support with specified hours of operation, and clearly states that user manuals and other product documentation are available upon request. While Tool A mentions an accessible user guide, Tool B's detailed support information suggests a more established and transparent support framework.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Salix Coronary Plaque | CAC Software |
|---|---|---|
| Product Name | Salix Coronary Plaque | CAC Software |
| Company | Artrya Limited | Imbio |
| Description | FDA-cleared, AI-driven, web-based software that provides near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease. | A set of automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). |
| Input Scan Type | CCTA scans | Non-contrast, chest computed tomography (CT) |
| Key Features | AI-enabled CCTA analysis, Near real-time, point-of-care assessment, Detection and quantification of coronary plaque (atherosclerosis), Identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification, positive remodeling, napkin-ring sign), Stenosis assessment, Quantification of calcifications (calcium scoring), Integrated workflow management, Automated report generation (editable). | Automated image post-processing for coronary artery calcification, Quantification of calcification within coronary arteries, Outputs Agatston score, arterial age, calcified lesion mass and volume, Provides 3D visualizations and annotated images, Non-invasive analysis from non-contrast chest CT scans, Integrates into existing DICOM viewing workflow, Supports risk assessment for coronary artery disease, Deep-learning based analysis. |
Videos
Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and CAC Software.